GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » ROC %

MicroTech Medical (Hangzhou) Co (HKSE:02235) ROC % : -65.85% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. MicroTech Medical (Hangzhou) Co's annualized return on capital (ROC %) for the quarter that ended in Jun. 2024 was -65.85%.

As of today (2025-03-29), MicroTech Medical (Hangzhou) Co's WACC % is 7.79%. MicroTech Medical (Hangzhou) Co's ROC % is -103.05% (calculated using TTM income statement data). MicroTech Medical (Hangzhou) Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


MicroTech Medical (Hangzhou) Co ROC % Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co ROC % Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROC %
-83.60 -119.04 -44.56 -67.46 -98.62

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC % Get a 7-Day Free Trial Premium Member Only -65.47 -76.91 -73.85 -149.66 -65.85

MicroTech Medical (Hangzhou) Co ROC % Calculation

MicroTech Medical (Hangzhou) Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-219.701 * ( 1 - -0.13% )/( (223.652 + 222.49)/ 2 )
=-219.9866113/223.071
=-98.62 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2561.852 - 52.765 - ( 2285.435 - max(0, 88.397 - 2431.069+2285.435))
=223.652

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2361.23 - 70.322 - ( 2068.418 - max(0, 102.136 - 2212.902+2068.418))
=222.49

MicroTech Medical (Hangzhou) Co's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-162.962 * ( 1 - 0.03% )/( (222.49 + 272.318)/ 2 )
=-162.9131114/247.404
=-65.85 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2361.23 - 70.322 - ( 2068.418 - max(0, 102.136 - 2212.902+2068.418))
=222.49

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2333.843 - 115.071 - ( 1946.454 - max(0, 162.365 - 2132.958+1946.454))
=272.318

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroTech Medical (Hangzhou) Co  (HKSE:02235) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, MicroTech Medical (Hangzhou) Co's WACC % is 7.79%. MicroTech Medical (Hangzhou) Co's ROC % is -103.05% (calculated using TTM income statement data). MicroTech Medical (Hangzhou) Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


MicroTech Medical (Hangzhou) Co ROC % Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroTech Medical (Hangzhou) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Orbimed Asia Partners V, L.p. 2101 Beneficial owner
Orbimed Asia Gp V, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors V Limited 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Ii, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Gp, L.p. 2201 Interest of corporation controlled by you
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Zheng Pan
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you

MicroTech Medical (Hangzhou) Co Headlines

No Headlines